Vanguard Group Inc Kala Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $0.36 $64,689 - $93,152	-258,757 Reduced 17.89%	1,187,957 $263,000
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $71,002 - $310,044	-236,675 Reduced 14.06%	1,446,714 $434,000
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $292,180 - $881,332	-478,985 Reduced 22.15%	1,683,389 $2.32 Million
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $119,591 - $282,483	-103,096 Reduced 4.55%	2,162,374 $2.62 Million
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $161,027 - $333,733	61,461 Added 2.79%	2,265,470 $5.94 Million

Q2 2021 Aug 13, 2021	BUY	$5.06 - $8.15 $11.2 Million - $18 Million	2,204,009 New	2,204,009 $11.7 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.